Merck KGaA Stock price

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 06:38:05 2024-03-28 am EDT 5-day change 1st Jan Change
164.2 EUR +2.50% Intraday chart for Merck KGaA +1.08% +13.36%
Sales 2024 * 21.28B 22.99B Sales 2025 * 22.54B 24.35B Capitalization 69.65B 75.24B
Net income 2024 * 2.96B 3.2B Net income 2025 * 3.44B 3.72B EV / Sales 2024 * 3.55 x
Net Debt 2024 * 5.92B 6.4B Net Debt 2025 * 3.96B 4.27B EV / Sales 2025 * 3.27 x
P/E ratio 2024 *
23.7 x
P/E ratio 2025 *
20.1 x
Employees 62,908
Yield 2024 *
1.39%
Yield 2025 *
1.51%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.53%
1 week+2.46%
Current month+1.52%
1 month+1.49%
3 months+12.18%
6 months+2.96%
Current year+11.17%
More quotes
1 week
156.50
Extreme 156.5
163.20
1 month
153.75
Extreme 153.75
163.20
Current year
140.50
Extreme 140.5
163.20
1 year
134.30
Extreme 134.3
176.75
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
56.30
Extreme 56.3
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 53 19-04-25
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Chairman 67 19-04-25
Director/Board Member 61 12-04-30
More insiders
Date Price Change Volume
24-03-28 163.4 +1.97% 55 811
24-03-27 160.2 +0.69% 299,813
24-03-26 159.1 -0.31% 255,538
24-03-25 159.6 -1.36% 165,432
24-03-22 161.8 +0.12% 209,833

Delayed Quote Xetra, March 27, 2024 at 12:35 pm EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (46.7%); - pharmaceutical products (35.3%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (18%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (5%), Switzerland (2.1%), Europe (21%), China (14.2%), Asia/Pacific (20.4%), the United States (27.1%), North America (1.5%), Latin America (5.5%), Middle East and Africa (3.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
160.2 EUR
Average target price
180.8 EUR
Spread / Average Target
+12.83%
Consensus
  1. Stock
  2. Equities
  3. Stock Merck KGaA - Xetra